Genizon BioSciences Adopts Illumina s BeadChips for Disease-Association Research | GenomeWeb

NEW YORK, Jan. 12 (GenomeWeb News) - Genizon BioSciences will use Illumina's whole-genome genotyping platform for its disease-association research program, Illumina said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.